Cita APA

Labrada, M., Clavell, M., Bebelagua, Y., De León, J., Alonso, D. F., Gabri, M. R., . . . Fernández, L. E. (2009). Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy. Web

Citación estilo Chicago

Labrada, Mayrel, Marilyn Clavell, Yanín Bebelagua, Joel De León, Daniel Fernando Alonso, Mariano Rolando Gabri, Roberto C. Veloso, Vicente Vérez, and Luis E. Fernández. Direct Validation of NGcGM3 Ganglioside As a New Target for Cancer Immunotherapy. 2009.

Cita MLA

Labrada, Mayrel, et al. Direct Validation of NGcGM3 Ganglioside As a New Target for Cancer Immunotherapy. 2009.